🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07036393
Recruiting Not applicable

Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries

NCT07036393 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-04-15
Last updated
2025-06-25

Condition(s) studied

AcupunctureTranscutaneous Electrical Nerve StimulationPainUpper Abdominal Surgery

Investigational drug(s) / intervention(s)

AcupunctureTranscutaneous electrical nerve stimulationdrugs

Acupuncture: Cholecystectomy involves a procedure where patients' spines are kept in position and skin around the acupoints is disinfected with 75% alcohol. Acupuncture treatment is given when patients return to units within 2 hours after surgery. The needles are inserted using disposable sterile needles and manipulated to induce a sense of "De qi" (soreness, numbness, distension, or heaviness). Gastrectomy involves daily acupuncture sessions for 5 consecutive days, starting on postoperative day 1. The needles are inserted perpendicular to the acupoints in the extremities to a depth of approximately 20 mm from the skin surface.

Transcutaneous electrical nerve stimulation: Patients will receive a transcutaneous electrical nerve stimulation unit (ENNRAF) for up to 48 hours post-surgery, with instructions to self-titrate intensity for pain relief. Postoperative stimulation will be 20-40 milliampere and pulse width 5

drugs: analgesics and nonsteroidal anti-inflammatory drugs

Study summary

This study was done to:

* Determine the therapeutic efficacy of acupuncture as physical therapy approach in minimizing pain post upper abdominal surgeries.
* Determine the therapeutic efficacy of transcutaneous electrical nerve stimulation in minimizing pain post upper abdominal surgeries.
* Compare the efficacy and safety of Transcutaneous electrical nerve stimulation versus acupuncture in minimizing pain post upper abdominal surgeries.

Eligibility

Sex
ALL
Min age
20 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who will have pain after upper abdominal surgery. * Adult patients will be between 20 and 45 years of age. * Both sexes will be included. * Patients have no contraindications for acupuncture or transcutaneous electrical nerve stimulation. * Patients with good compliance and fit for treatment. * This study will be applied on upper abdominal surgeries \[laparoscopic cholecystectomy, Gastrectomy\]. * Physical therapy will be used for up to 48 hours after surgery or until the time of discharge. Exclusion Criteria: * Patients with other causes of pain other than that after upper abdominal surgery. * Patients who will have any contraindication for both therapies used. * Patients with cardiovascular disease, liver, or renal disease. * Patients with malignant tumors. * Patients with metal or electronic implants. * Patients with autoimmune disease. * Pregnancy, postpartum period, breastfeeding. * Patients with recent injury in the treatment area

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mansoura international hospital Al Mansurah Egypt Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07036393 on ClinicalTrials.gov ↗ ← All trials in Egypt